Biocon launches Ustekinumab biosimilar Yesintek in US market
MUMBAI: Biocon Biologics Ltd has announced the US launch of Yesintek (ustekinumab-kfce), one of the first biosimila
switch
switch
switch
Newsletter Subscription
Subscribe To Our Newsletter
